BIOINTESTIL

Serial Number 79336519
Registration 7333715
700

Registration Progress

Application Filed
Nov 12, 2021
Under Examination
Approved for Publication
Jan 9, 2024
Published for Opposition
Jan 9, 2024
Registered
Mar 26, 2024

Basic Information

Serial Number
79336519
Registration Number
7333715
Filing Date
November 12, 2021
Registration Date
March 26, 2024
Published for Opposition
January 9, 2024
Drawing Code
5

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 26, 2024
Registration
Registered
Classes
005

Rights Holder

Targeting Gut Disease S.r.l.

99
Address
Viale G. Fanin 48
I-40127 Bologna
IT

Ownership History

Targeting Gut Disease S.r.l.

Original Applicant
99
IT

Targeting Gut Disease S.r.l.

Owner at Publication
99
IT

Targeting Gut Disease S.r.l.

Original Registrant
99
IT

Legal Representation

Attorney
Alexander Lazouski

USPTO Deadlines

Next Renewal Deadline
1722 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-03-26)
Due Date
March 26, 2030
Grace Period Ends
September 26, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

28 events
Date Code Type Description
Nov 17, 2024 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 7, 2024 FIMP P FINAL DISPOSITION PROCESSED
Oct 7, 2024 FICS P FINAL DISPOSITION NOTICE SENT TO IB
Jun 27, 2024 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 26, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 26, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER
Jan 9, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 9, 2024 PUBO A PUBLISHED FOR OPPOSITION
Jan 7, 2024 GPNX P NOTIFICATION PROCESSED BY IB
Dec 20, 2023 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 20, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 20, 2023 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 5, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 16, 2023 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 30, 2023 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 30, 2023 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 11, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 10, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 10, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 8, 2022 RFNT P REFUSAL PROCESSED BY IB
Oct 15, 2022 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 15, 2022 RFRR P REFUSAL PROCESSED BY MPU
Aug 26, 2022 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 25, 2022 CNRT R NON-FINAL ACTION WRITTEN
Aug 24, 2022 DOCK D ASSIGNED TO EXAMINER
Mar 29, 2022 MAFR O APPLICATION FILING RECEIPT MAILED
Mar 25, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 24, 2022 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB

Detailed Classifications

Class 005
Probiotic dietary supplements; dietary, vitamin, nutritional and mineral supplements and dietetic food supplements; pharmaceuticals, namely, anti-infectives, antimicrobial, antioxidant and anti-inflammatory; dietetic food and beverages adapted for medical use; infant formula; food supplements for humans

Additional Information

Design Mark
The mark consists of the stylized wording "BIOINTESTIL" with the verbal part "BIO" in capital letters and the verbal part "INTESTIL" in lower case.

Classification

International Classes
005